Source: STREETINSIDER

Press Release: Illumina : PierianDx Announces Multi-Year Agreement with Illumina to Support Cancer Research and Diagnostics

PierianDx, a leading clinical genomics informatics company, today announced a strategic, non-exclusive, multi-year partnership with Illumina, Inc. to provide a variant interpretation and reporting solution based on PierianDx’s Clinical Genomics Workspace platform

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from Illumina's latest SEC filings

Annual Revenue

Based on data from Illumina's latest SEC filings

Employees

Francis deSouza's photo - President & CEO of Illumina

President & CEO

Francis deSouza

CEO Approval Rating

72/100

Illumina develops, manufactures and markets integrated systems for the analysis of genetic variation and biological func... Read more